Box 3
Container
Contains 19 Results:
Canada (II), 1991-2000
File — Box: 3, Folder: 1-3
Accession: 2492Identifier: 2492-II.
Scope and Contents note:
3 files.
Dates:
1991-2000
Canada patent dispute, 2000 March
File — Box: 3, Folder: 4
Accession: 2492Identifier: 2492-II.
Dates:
2000 March
COLC International, 1989
File — Box: 3, Folder: 5
Accession: 2492Identifier: 2492-II.
Scope and Contents note:
Anti-counterfeiting Committee.
Dates:
1989
Congress - Fast Track authority re NAFTA, 1977
File — Box: 3, Folder: 6
Accession: 2492Identifier: 2492-II.
Dates:
1977
Congress - Fast Track extensions, 1990-1995
File — Box: 3, Folder: 7
Accession: 2492Identifier: 2492-II.
Dates:
1990-1995
Congress - House Foreign Affairs Committee hearing, 1994
File — Box: 3, Folder: 8
Accession: 2492Identifier: 2492-II.
Scope and Contents note:
Testimony of Jacques Gorlin.
Dates:
1994
Congress - House Ways and Means Committee, 1989, 1992, 1993
File — Box: 3, Folder: 9
Accession: 2492Identifier: 2492-II.
Scope and Contents note:
Testimony of - Pfizer Inc. executives Peter C. Richardson and C.L. Clemente
Dates:
1989; 1992; 1993
Congress - House Ways and Means Committee hearing, 1994-1997
File — Box: 3, Folder: 10
Accession: 2492Identifier: 2492-II.
Scope and Contents note:
Testimony of IPC.
Dates:
1994-1997
Congress - Lautenberg (Frank R.) Bill on GSP/IP (1997), 1997-1999
File — Box: 3, Folder: 11
Accession: 2492Identifier: 2492-II.
Scope and Contents note:
Bill submitted to Congress to amend the Generalized System of Preferences Act.
Dates:
1997-1999
Congress - Manufacturing clause, 1986
File — Box: 3, Folder: 12
Accession: 2492Identifier: 2492-II.
Dates:
1986
Congress - MPAA draft IP legislation, 1986-1987
File — Box: 3, Folder: 13
Accession: 2492Identifier: 2492-II.
Dates:
1986-1987
Congress - Murkowski's Amendment to Sec. 204 on patent suppression, 1989 September
File — Box: 3, Folder: 14
Accession: 2492Identifier: 2492-II.
Dates:
1989 September
Congress - NAFTA impending legislation, 1992-1993
File — Box: 3, Folder: 15
Accession: 2492Identifier: 2492-II.
Dates:
1992-1993
Congress - Senate Finance Committee hearings, 1993
File — Box: 3, Folder: 16
Accession: 2492Identifier: 2492-II.
Dates:
1993
Congress - Senate Finance Committee hearings, 1986-1991
File — Box: 3, Folder: 17
Accession: 2492Identifier: 2492-II.
Scope and Contents note:
Testimony of - Kenneth W. Dam, IBM July 23, 1986; C. L. Clemente, Pfizer Inc. April 20, 1989; Edmund T. Pratt, Jr., Pfizer Inc. November 20, 1991.
Dates:
1986-1991
Congress - Senate Judiciary Committee hearing, 1991
File — Box: 3, Folder: 18
Accession: 2492Identifier: 2492-II.
Scope and Contents note:
Testimony of - C. L. Clemente, Pfizer Inc. May 16, 1991.
Dates:
1991
Congress - Uruguay Round implementing legislation/amendments (1994), 1994
File — Box: 3, Folder: 19
Accession: 2492Identifier: 2492-II.
Scope and Contents note:
Includes letters written to members of Congress urging support for passage of the GATT Uruguay Round Agreement.
Dates:
1994
EFPIA, 1991-1996
File — Box: 3, Folder: 20
Accession: 2492Identifier: 2492-II.
Scope and Contents note:
European Federation of Pharmaceutical Industries Association
Dates:
1991-1996
FTAA (Free Trade Area of the Americas) - Task Force, 1995-2002
File — Box: 3, Folder: 21-22
Accession: 2492Identifier: 2492-II.
Scope and Contents note:
2 files.
Dates:
1995-2002
